ERGOT ERYNGO ERYNGIUM CAMPESTRE

ERGOT (Claviceps purpurea) X

Activities (Ergot) :
Ecbolic (1; EFS); Emmenagogue (1; EFS); Hemostat (1; EFS); Toxic (1;EFS); Uterotonic (1; EFS).

Indications (Ergot) :
Atonia (f; PH2); Bleeding (f; EFS; PH2); Childbirth (f; PH2); Circulosis (f; PH2); Convulsion (f; PH2); Cramp (f; PH2); Menorrhagia (f; PH2); Metrorrhagia (f; PH2); Migraine (1; PH2); Myosis (f; PH2); Paralysis (f; PH2); Uterosis (f; PH2).

Dosages (Ergot) :
Too dangerous.

Contraindications, Interactions, and Side Effects (Ergot) :
Ergot is now contraindicated for all therapeutic use (PH2). Not covered nor recommended any more, though ergotamine is still used for migraine (prescription only, I suppose).


ERYNGO (Eryngium campestre L.) ++

Activities (Eryngo) :
Antispasmodic (f; PH2); Aphrodisiac (f; HHB); Diuretic (f; PH2); Expectorant (f; PH2).

Indications (Eryngo) :
Amenorrhea (f; HHB); Bladder Stone (f; PH2); Blister (f; HHB); Bronchosis (f; HHB; PH2); Cancer (f; JLH); Catarrh (f; PH2); Cramp (f; PH2); Cystosis (f; HHB); Dermatosis (f; PH2); Edema (f; HHB; PH2); Hepatosis (f; HHB); Inflammation (f; JLH; PH2); Jaundice (f; HHB); Kidney Stone (f; PH2); Nephrosis (f; PH2); Prostatosis (f; HHB; PH2); Splenosis (f; HHB); Urethrosis (f; PH2); UTI (f; PH2); Water Retention (f; PH2).

Dosages (Eryngo) :
1 tsp root/cup, 3 - 4 cups/day (PH2); root boiled in red wine with honey for cancer (JLH).

Contraindications, Interactions, and Side Effects (Eryngo) :
Class 1 for Eryngo (E. maritinum, E, planum, and E. yuccifolium as eryngo or sea holly) (AHP). Hazards and/or side effects not recorded for proper therapeutic dosages (PH2).